195 related articles for article (PubMed ID: 32086932)
1. [Research progress on the relationship between cisplatin ototoxicity and autophagy].
Liang Z; Cheng G; Zhang T; Jia H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 34(2):189-192. PubMed ID: 32086932
[No Abstract] [Full Text] [Related]
2. Cisplatin-Induced Ototoxicity: Updates on Molecular Targets.
Gentilin E; Simoni E; Candito M; Cazzador D; Astolfi L
Trends Mol Med; 2019 Dec; 25(12):1123-1132. PubMed ID: 31473143
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
[TBL] [Abstract][Full Text] [Related]
4. Role of autophagy in cisplatin-induced ototoxicity.
Youn CK; Kim J; Park JH; Do NY; Cho SI
Int J Pediatr Otorhinolaryngol; 2015 Nov; 79(11):1814-9. PubMed ID: 26307546
[TBL] [Abstract][Full Text] [Related]
5. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
6. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
Peleva E; Emami N; Alzahrani M; Bezdjian A; Gurberg J; Carret AS; Daniel SJ
Pediatr Blood Cancer; 2014 Nov; 61(11):2012-7. PubMed ID: 24976616
[TBL] [Abstract][Full Text] [Related]
7. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
8. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.
Yancey A; Harris MS; Egbelakin A; Gilbert J; Pisoni DB; Renbarger J
Pediatr Blood Cancer; 2012 Jul; 59(1):144-8. PubMed ID: 22431292
[TBL] [Abstract][Full Text] [Related]
10. Prevention and restoration of hearing loss associated with the use of cisplatin.
Chirtes F; Albu S
Biomed Res Int; 2014; 2014():925485. PubMed ID: 25140325
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance system.
Stöhr W; Langer T; Kremers A; Bielack S; Lamprecht-Dinnesen A; Frey E; Beck JD;
Cancer Invest; 2005; 23(3):201-7. PubMed ID: 15945505
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of cisplatin-induced ototoxicity.
Mukherjea D; Rybak LP
Pharmacogenomics; 2011 Jul; 12(7):1039-50. PubMed ID: 21787192
[TBL] [Abstract][Full Text] [Related]
13. ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring.
Dille MF; Ellingson RM; McMillan GP; Konrad-Martin D
J Am Acad Audiol; 2013 Oct; 24(9):769-81. PubMed ID: 24224985
[TBL] [Abstract][Full Text] [Related]
14. Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
Bass JK; Huang J; Onar-Thomas A; Chang KW; Bhagat SP; Chintagumpala M; Bartels U; Gururangan S; Hassall T; Heath JA; McCowage G; Cohn RJ; Fisher MJ; Robinson G; Broniscer A; Gajjar A; Gurney JG
Pediatr Blood Cancer; 2014 Apr; 61(4):601-5. PubMed ID: 24504791
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.
Lanvers-Kaminsky C; Ciarimboli G
Pharmacogenomics; 2017 Dec; 18(18):1683-1695. PubMed ID: 29173064
[TBL] [Abstract][Full Text] [Related]
16. Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.
Kros CJ; Steyger PS
Cold Spring Harb Perspect Med; 2019 Nov; 9(11):. PubMed ID: 30559254
[TBL] [Abstract][Full Text] [Related]
17. Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin.
Sriyapai T; Thongyai K; Phuakpet K; Vathana N; Buaboonnam J; Sanpakit K
Turk J Pediatr; 2022; 64(3):531-541. PubMed ID: 35899566
[TBL] [Abstract][Full Text] [Related]
18. New insights into cisplatin ototoxicity.
Brock PR
Cancer; 2022 Jan; 128(1):43-46. PubMed ID: 34490622
[TBL] [Abstract][Full Text] [Related]
19. Metformin alleviates cisplatin-induced ototoxicity by autophagy induction possibly via the AMPK/FOXO3a pathway.
Liang Z; Zhang T; Zhan T; Cheng G; Zhang W; Jia H; Yang H
J Neurophysiol; 2021 Apr; 125(4):1202-1212. PubMed ID: 33625942
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin ototoxicity in children: risk factors and its relationship with polymorphisms of DNA repair genes ERCC1, ERCC2, and XRCC1.
Turan C; Kantar M; Aktan Ç; Kosova B; Orman M; Bilgen C; Kirazlı T
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1333-1338. PubMed ID: 31586226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
